Darren Pan (@DarrenPanMD) header
Darren Pan (@DarrenPanMD) profile picture

Myeloma Doc @UCSF Focused on CAR-T, bispecifics & high-risk myeloma/EMD Views are my own

Joined September 2016
My old mentor @JoshuaRichterMD with another great presentation on immunotherapy -discussing importance of giving T-cells a break whenever possible, highlights the need for more T-cell sparing therapies that don’t always get as much buzz as CAR-Ts and bi/trispecifics
Huge thanks to @HealthTree @PeerView and @Myeloma_Society for allowing me the privilege to talk about immunotherapy sequencing and Oreo cookies at #IMS26. This has been such a wonderful congress ! #mmsm @TischCancer
1
4
1,263
Fantastic review of how we tackle major myeloma treatment decisions by my former co-fellow, Tarek! 👏
Grateful for the opportunity to contribute this review on multiple myeloma with Dr. Kenneth Anderson. We discuss the rapidly evolving treatment landscape and how emerging therapies are reshaping the approach to myeloma. @DanaFarber #mmsm #multiplemyeloma #myeloma
2
2,423
When #MultipleMyeloma returns or stops responding to treatment, GPRC5D offers a new target. A new review examines therapies targeting GPRC5D and emerging strategies that could broaden treatment options. 🔗 acsjournals.onlinelibrary.wi… @OncoAlert @DarrenPanMD @AjaiChari
2
10
15
1,127
Darren Pan retweeted
Congratulations to @David_Oh_MD @UCSFCancer and @MikeKattahMD on receiving NCI R01 award for collaboration on BCMA CAR-T enterocolitis! Exciting work using spatial & functional models to uncover mechanisms and advance MM therapies.
2
10
1
39
3,391
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review [May 28, 2025] @DarrenPanMD et al. @AjaiChari @EO_InvDrugs tandfonline.com/doi/10.1080/… #mmsm #PrecisionMedicine #CARTcell
5
9
858
Darren Pan retweeted
Congratulations to @simone_minnie on Gabrielle's Angel Foundation for Cancer Research award re "Augmenting in vivo CAR T cell therapy with engineered cytokines" !
1
4
13
1,557
Link to article in @AjHematology, also adding other co-authors including @bhemato @DarrenPanMD and more. Lots of nuances in text around recommendations above, e.g. post-ASCT maintenance and what we'd actually recommend for our own patients (and why). onlinelibrary.wiley.com/doi/…
1
3
14
955
Darren Pan retweeted
Outstanding presentation by @AlfredChung11 on MRD dynamics in Auriga study showing benefit of daratumumab in deepening and sustained responses.
5
15
753
Short survival with BCMA and GPRC5D dual antigen exposed relapsed myeloma [DEMM] - an international myeloma working group [IMWG] immunotherapy database analysis [Nov 3, 2025] @JanakiramMurali et al. #ASH25 abs25-14454 PID 4598 meetings-api.hematology.org/… #mmsm #ImmunoOnc
3
6
445
How should we choose optimal salvage treatments following BCMA-directed CAR-T therapy in multiple myeloma? Check out our review article out today summarizing recent studies and our approach to therapy sequencing from our team @UCSFCancer 👇 #MMsm #myeloma dx.doi.org/10.1080/1750743X.…
1
15
46
2,907
We want to share this important toxicity profile of GPRC5D BisAb- Talquetamab. GPRC5D Bispecific antibody talquetamab-induced dizziness-ataxia syndrome, clinical presentation and management- a case series nature.com/articles/s41408-0… Full link- rdcu.be/eAazx
7
32
2
72
10,189
Darren Pan retweeted
Delayed cart neurotox -likely 4 risk factors demographics, disease burden, high grade crs/icans, peak CAR expansion. However rare so requires continued international collaborations- outstanding work by Dr Kumar and global contributors!
Delayed neurotoxicity poster with my mentor @AjaiChari
2
10
54
4,718
Delayed neurotoxicity poster with my mentor @AjaiChari
4
7
1
38
16,994
Why? Excellent #IMS24 plenary by Machlachlan @MSKCancerCenter 👇 PMD and EMD look very different at a genomic level, and we should stop conflating them. Kudos to many junior faculty @ZanwarSaurabh @DimaDanai @AimazAfrough @DarrenPanMD et al who’ve helped show this clinically!
1
5
14
3,306
Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma pubmed.ncbi.nlm.nih.gov/3914… @DarrenPanMD @JoshuaRichterMD @IcahnMountSinai #MultipleMyeloma
7
15
1,136
I’m beyond touched to receive this from ⁦@DarrenPanMD⁩ He says that I always have myeloma on my mind. 😀. Looking forward to years of collaboration between ⁦@UCSFCancer⁩ and ⁦@TischCancer⁩ #mmsm
7
7
83
4,136